CrimsonHeart的个人主页 - 老虎社区

CrimsonHeart

CrimsonHeart

暂无个人介绍

IP属地：未知

17关注

1粉丝

0主题

0勋章

2021-01-30

......

2021-12-23

:D

Wall St mints strong gains on rosy economic data, encouraging Omicron update

2021-12-23

Hi

HUBS Stock Alert: 8 Things to Know About the New HubSpot Short Report

2021-12-23

Weeeeee

2021-02-10

O.o...

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3573977348324837","uuid":"3573977348324837","gmtCreate":1610884148056,"gmtModify":1640230220262,"name":"CrimsonHeart","pinyin":"crimsonheart","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/c790b0ebdf77e67f8dccdd2fe317727f","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":17,"tweetSize":5,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"资深虎友","description":"加入老虎社区1000天","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.10.17","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.65%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":3,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":691422974,"gmtCreate":1640230337572,"gmtModify":1640230406468,"author":{"id":"3573977348324837","authorId":"3573977348324837","name":"CrimsonHeart","avatar":"https://static.tigerbbs.com/c790b0ebdf77e67f8dccdd2fe317727f","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573977348324837","authorIdStr":"3573977348324837"},"themes":[],"htmlText":"Weeeeee","listText":"Weeeeee","text":"Weeeeee","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691422974","isVote":1,"tweetType":1,"viewCount":501,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691428502,"gmtCreate":1640230158215,"gmtModify":1640230158310,"author":{"id":"3573977348324837","authorId":"3573977348324837","name":"CrimsonHeart","avatar":"https://static.tigerbbs.com/c790b0ebdf77e67f8dccdd2fe317727f","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573977348324837","authorIdStr":"3573977348324837"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691428502","repostId":"1137875320","repostType":4,"repost":{"id":"1137875320","kind":"news","pubTimestamp":1640228882,"share":"https://www.laohu8.com/m/news/1137875320?lang=&edition=full","pubTime":"2021-12-23 11:08","market":"us","language":"en","title":"HUBS Stock Alert: 8 Things to Know About the New HubSpot Short Report","url":"https://stock-news.laohu8.com/highlight/detail?id=1137875320","media":"InvestorPlace","summary":"Shares of HubSpot(NYSE:HUBS) have been on an absolute tear since the March 2020 pandemic lows. The m","content":"<p>Shares of&nbsp;<b>HubSpot</b>(NYSE:<b><u>HUBS</u></b>) have been on an absolute tear since the March 2020 pandemic lows. The marketing software solutions company has appreciated more than 450% since then. This return certainly beat the&nbsp;<b>S&amp;P 500’s</b>&nbsp;return of 103% during the same time period. However, a new short report released today by an influential hedge fund has investors of HUBS stock concerned.</p>\n<p><b>Kerrisdale Capital</b>, a New York based hedge fund, issued a scathing&nbsp;short report&nbsp;on HUBS stock. The fund believes that HubSpot is a massively overvalued coronavirus beneficiary that lacks a real moat. A moat is a competitive advantage that a company has that gives it a unique edge over competitors. Additionally, a moat gives a company power to control market share and sales. Kerrisdale adds that HubSpot is unprofitable, yet still trades at 20x forward revenue.</p>\n<p>Shares of HUBS stock have remained relatively resilient in the wake of Kerrisdale’s short report, down less than 2%. However, when Kerrisdale talks, people listen. Let’s dive into the details on the HubSpot short report.</p>\n<p>What to Know About the Kerrisdale Short Report Rocking HUBS Stock</p>\n<ol>\n <li>Kerrisdale highlights that HubSpot has a recent history of major executives leaving. In the past few years, the company has lost its CEO, chief operating officer, chief sales officer and chief strategy officer.</li>\n <li>Prior to the 2020 pandemic, HubSpot’s revenue growth was in decline for several years. Kerrisdale gives credit to HubSpot for growing revenues after the pandemic due to mid-sized businesses rushing to go digital. However, the hedge fund argues that the price of HubSpot is now trading at a premium relative to industry peers for no solid reason.</li>\n <li>Indeed, industry peers&nbsp;<b>SquareSpace</b>(NYSE:<b><u>SQSP</u></b>)&nbsp;and&nbsp;<b>Wix</b>(NASDAQ:<b><u>WIX</u></b>) trade at an enterprise value to next 12 months revenue (EV/NTM revenue) multiple of 5.1x and 5.7x, respectively. Meanwhile, HubSpot trades at a 20x EV/NTM sales multiple.</li>\n <li>Kerrisdale believes this multiple will be unsustainable for HubSpot as pandemic beneficiary companies start to return to normal and investors begin questioning unprofitable companies.</li>\n <li>According to Kerrisdale’s research and interviews with online marketing professionals, HubSpot’s products are “‘good enough’ for many purposes but don’t possess any sort of commanding lead in capabilities or ease of use.” The hedge fund cites several online reviews that mention that the company’s variety of products doesn’t offer any real utility. Furthermore, several online reviews detail the difficulty of HubSpot’s learning curve and expensive prices.</li>\n <li>Moreover, HubSpot has raised capital in the past few years “with no obvious use for it.” The company conducted a $343 million secondary equity offering in 2019 and issued convertible bonds worth $460 million in 2020. Kerrisdale explains that all of the cash raised from these two transactions is still sitting on the balance sheet. The hedge fund believes that the cash was simply raised to extend HubSpot’s financial runway. Moreover, the capital raise took advantage of “share prices that seemed high at the time (yet now imply dramatic downside for the stock).”</li>\n <li>As the digital transformation moves on, competitors to HubSpot are receiving capital easily. Kerrisdale highlights<b>Klaviyo</b>,<b>Mailchimp</b>&nbsp;and&nbsp;<b>SharpSpring</b>&nbsp;as three major competitors. Kerrisdale mentions that: “With its startup days now long behind it, HubSpot isn’t the disruptor; it’s the disruptee.”</li>\n <li>Finally, Kerrisdale Capital disclosed that it is short shares of HUBS stock.</li>\n</ol>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HUBS Stock Alert: 8 Things to Know About the New HubSpot Short Report</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHUBS Stock Alert: 8 Things to Know About the New HubSpot Short Report\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-23 11:08 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/12/hubs-stock-alert-8-things-to-know-about-the-new-hubspot-short-report/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of HubSpot(NYSE:HUBS) have been on an absolute tear since the March 2020 pandemic lows. The marketing software solutions company has appreciated more than 450% since then. This return certainly...</p>\n\n<a href=\"https://investorplace.com/2021/12/hubs-stock-alert-8-things-to-know-about-the-new-hubspot-short-report/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HUBS":"HubSpot"},"source_url":"https://investorplace.com/2021/12/hubs-stock-alert-8-things-to-know-about-the-new-hubspot-short-report/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1137875320","content_text":"Shares of HubSpot(NYSE:HUBS) have been on an absolute tear since the March 2020 pandemic lows. The marketing software solutions company has appreciated more than 450% since then. This return certainly beat the S&P 500’s return of 103% during the same time period. However, a new short report released today by an influential hedge fund has investors of HUBS stock concerned.\nKerrisdale Capital, a New York based hedge fund, issued a scathing short report on HUBS stock. The fund believes that HubSpot is a massively overvalued coronavirus beneficiary that lacks a real moat. A moat is a competitive advantage that a company has that gives it a unique edge over competitors. Additionally, a moat gives a company power to control market share and sales. Kerrisdale adds that HubSpot is unprofitable, yet still trades at 20x forward revenue.\nShares of HUBS stock have remained relatively resilient in the wake of Kerrisdale’s short report, down less than 2%. However, when Kerrisdale talks, people listen. Let’s dive into the details on the HubSpot short report.\nWhat to Know About the Kerrisdale Short Report Rocking HUBS Stock\n\nKerrisdale highlights that HubSpot has a recent history of major executives leaving. In the past few years, the company has lost its CEO, chief operating officer, chief sales officer and chief strategy officer.\nPrior to the 2020 pandemic, HubSpot’s revenue growth was in decline for several years. Kerrisdale gives credit to HubSpot for growing revenues after the pandemic due to mid-sized businesses rushing to go digital. However, the hedge fund argues that the price of HubSpot is now trading at a premium relative to industry peers for no solid reason.\nIndeed, industry peers SquareSpace(NYSE:SQSP) and Wix(NASDAQ:WIX) trade at an enterprise value to next 12 months revenue (EV/NTM revenue) multiple of 5.1x and 5.7x, respectively. Meanwhile, HubSpot trades at a 20x EV/NTM sales multiple.\nKerrisdale believes this multiple will be unsustainable for HubSpot as pandemic beneficiary companies start to return to normal and investors begin questioning unprofitable companies.\nAccording to Kerrisdale’s research and interviews with online marketing professionals, HubSpot’s products are “‘good enough’ for many purposes but don’t possess any sort of commanding lead in capabilities or ease of use.” The hedge fund cites several online reviews that mention that the company’s variety of products doesn’t offer any real utility. Furthermore, several online reviews detail the difficulty of HubSpot’s learning curve and expensive prices.\nMoreover, HubSpot has raised capital in the past few years “with no obvious use for it.” The company conducted a $343 million secondary equity offering in 2019 and issued convertible bonds worth $460 million in 2020. Kerrisdale explains that all of the cash raised from these two transactions is still sitting on the balance sheet. The hedge fund believes that the cash was simply raised to extend HubSpot’s financial runway. Moreover, the capital raise took advantage of “share prices that seemed high at the time (yet now imply dramatic downside for the stock).”\nAs the digital transformation moves on, competitors to HubSpot are receiving capital easily. Kerrisdale highlightsKlaviyo,Mailchimp and SharpSpring as three major competitors. Kerrisdale mentions that: “With its startup days now long behind it, HubSpot isn’t the disruptor; it’s the disruptee.”\nFinally, Kerrisdale Capital disclosed that it is short shares of HUBS stock.","news_type":1},"isVote":1,"tweetType":1,"viewCount":540,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691421468,"gmtCreate":1640230064615,"gmtModify":1640230064671,"author":{"id":"3573977348324837","authorId":"3573977348324837","name":"CrimsonHeart","avatar":"https://static.tigerbbs.com/c790b0ebdf77e67f8dccdd2fe317727f","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573977348324837","authorIdStr":"3573977348324837"},"themes":[],"htmlText":":D","listText":":D","text":":D","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691421468","repostId":"2193113147","repostType":4,"repost":{"id":"2193113147","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640213688,"share":"https://www.laohu8.com/m/news/2193113147?lang=&edition=full","pubTime":"2021-12-23 06:54","market":"us","language":"en","title":"Wall St mints strong gains on rosy economic data, encouraging Omicron update","url":"https://stock-news.laohu8.com/highlight/detail?id=2193113147","media":"Reuters","summary":"* Tesla jumps as CEO Musk says he has sold 'enough' stock. * Pfizer rises as oral COVID-19 pill wins approval. Dec 22  - Wall Street's main indexes powered higher on Wednesday in a broad rally after upbeat economic data and hopeful developments about the severity of the Omicron coronavirus variant that is sweeping the world.The S&P 500 gained at least 1% for a second straight session, putting it near record levels, as volatility has ratcheted up in the last month of 2021 following the arrival of","content":"<p>* Consumer confidence index increases in December</p>\n<p>* U.S. Q3 economic growth revised slightly higher</p>\n<p>* Tesla jumps as CEO Musk says he has sold 'enough' stock</p>\n<p>* Pfizer rises as oral COVID-19 pill wins approval</p>\n<p>* Indexes up: Dow 0.74%, S&amp;P 1.02%, Nasdaq 1.18% </p>\n<p>Dec 22 (Reuters) - Wall Street's main indexes powered higher on Wednesday in a broad rally after upbeat economic data and hopeful developments about the severity of the Omicron coronavirus variant that is sweeping the world.</p>\n<p>The S&amp;P 500 gained at least 1% for a second straight session, putting it near record levels, as volatility has ratcheted up in the last month of 2021 following the arrival of Omicron and an otherwise strong year for equities.</p>\n<p>A South African study suggested reduced risks of hospitalization and severe disease in people infected with the Omicron variant versus the Delta one, but World Health Organization officials cautioned that it was too soon to draw firm conclusions.</p>\n<p>“We are still struggling for direction in the face of the Omicron outbreak, but in the past few days ... more and more evidence is building that the strain is potentially less severe than prior strains, specifically Delta, which bodes well for economic momentum in 2022,” said Mike Stritch, chief investment officer at BMO Wealth Management.</p>\n<p>The Dow Jones Industrial Average rose 261.19 points, or 0.74%, to 35,753.89, the S&amp;P 500 gained 47.33 points, or 1.02%, to 4,696.56 and the Nasdaq Composite added 180.81 points, or 1.18%, to 15,521.89.</p>\n<p>All major S&amp;P 500 sectors gained, with the consumer discretionary group up 1.7% and technology up 1.3%.</p>\n<p>Tesla Inc shares rose 7.5%, boosting the S&amp;P 500 and Nasdaq. Tesla Chief Executive Elon Musk said in an interview he has sold \"enough stock\" following several weeks of share sales by the billionaire.</p>\n<p>U.S. consumer confidence improved further in December, suggesting the economy would continue to expand in 2022. The survey from the Conference Board showed more consumers planned to buy a house and big-ticket items such as motor vehicles and major household appliances as well as go on vacation over the next six months.</p>\n<p>Other reports showed U.S. home sales increased for a third straight month in November, and that gross domestic product increased at a 2.3% annualized rate in the July-September quarter, revised up from the 2.1% rate estimated last month.</p>\n<p>In another encouraging development against the pandemic, the United States authorized Pfizer Inc's oral antiviral COVID-19 pill for at-risk people aged 12 and above, making it the first at-home treatment for the coronavirus. Pfizer shares rose 1%.</p>\n<p>The benchmark S&amp;P 500 is now up 25% so far in 2021. Still, the environment for equities could be changing heading into next year as the Federal Reserve is expected to begin raising interest rates in 2022 to rein in inflation.</p>\n<p>The market is \"certainly at an extended level of valuation,\" said Rick Meckler, partner at Cherry Lane Investments in New Vernon, New Jersey. “Next year is a more difficult picture, but if inflation is going to be part of the problem, I think investors will certainly choose stocks over bonds.”</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 3.17-to-1 ratio; on Nasdaq, a 1.65-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 15 new 52-week highs and no new lows; the Nasdaq Composite recorded 35 new highs and 99 new lows.</p>\n<p>About 8.6 billion shares changed hands in U.S. exchanges, below the 11.8 billion daily average over the last 20 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St mints strong gains on rosy economic data, encouraging Omicron update</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St mints strong gains on rosy economic data, encouraging Omicron update\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-23 06:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* Consumer confidence index increases in December</p>\n<p>* U.S. Q3 economic growth revised slightly higher</p>\n<p>* Tesla jumps as CEO Musk says he has sold 'enough' stock</p>\n<p>* Pfizer rises as oral COVID-19 pill wins approval</p>\n<p>* Indexes up: Dow 0.74%, S&amp;P 1.02%, Nasdaq 1.18% </p>\n<p>Dec 22 (Reuters) - Wall Street's main indexes powered higher on Wednesday in a broad rally after upbeat economic data and hopeful developments about the severity of the Omicron coronavirus variant that is sweeping the world.</p>\n<p>The S&amp;P 500 gained at least 1% for a second straight session, putting it near record levels, as volatility has ratcheted up in the last month of 2021 following the arrival of Omicron and an otherwise strong year for equities.</p>\n<p>A South African study suggested reduced risks of hospitalization and severe disease in people infected with the Omicron variant versus the Delta one, but World Health Organization officials cautioned that it was too soon to draw firm conclusions.</p>\n<p>“We are still struggling for direction in the face of the Omicron outbreak, but in the past few days ... more and more evidence is building that the strain is potentially less severe than prior strains, specifically Delta, which bodes well for economic momentum in 2022,” said Mike Stritch, chief investment officer at BMO Wealth Management.</p>\n<p>The Dow Jones Industrial Average rose 261.19 points, or 0.74%, to 35,753.89, the S&amp;P 500 gained 47.33 points, or 1.02%, to 4,696.56 and the Nasdaq Composite added 180.81 points, or 1.18%, to 15,521.89.</p>\n<p>All major S&amp;P 500 sectors gained, with the consumer discretionary group up 1.7% and technology up 1.3%.</p>\n<p>Tesla Inc shares rose 7.5%, boosting the S&amp;P 500 and Nasdaq. Tesla Chief Executive Elon Musk said in an interview he has sold \"enough stock\" following several weeks of share sales by the billionaire.</p>\n<p>U.S. consumer confidence improved further in December, suggesting the economy would continue to expand in 2022. The survey from the Conference Board showed more consumers planned to buy a house and big-ticket items such as motor vehicles and major household appliances as well as go on vacation over the next six months.</p>\n<p>Other reports showed U.S. home sales increased for a third straight month in November, and that gross domestic product increased at a 2.3% annualized rate in the July-September quarter, revised up from the 2.1% rate estimated last month.</p>\n<p>In another encouraging development against the pandemic, the United States authorized Pfizer Inc's oral antiviral COVID-19 pill for at-risk people aged 12 and above, making it the first at-home treatment for the coronavirus. Pfizer shares rose 1%.</p>\n<p>The benchmark S&amp;P 500 is now up 25% so far in 2021. Still, the environment for equities could be changing heading into next year as the Federal Reserve is expected to begin raising interest rates in 2022 to rein in inflation.</p>\n<p>The market is \"certainly at an extended level of valuation,\" said Rick Meckler, partner at Cherry Lane Investments in New Vernon, New Jersey. “Next year is a more difficult picture, but if inflation is going to be part of the problem, I think investors will certainly choose stocks over bonds.”</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 3.17-to-1 ratio; on Nasdaq, a 1.65-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 15 new 52-week highs and no new lows; the Nasdaq Composite recorded 35 new highs and 99 new lows.</p>\n<p>About 8.6 billion shares changed hands in U.S. exchanges, below the 11.8 billion daily average over the last 20 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)",".IXIC":"NASDAQ Composite","BK4568":"美国抗疫概念","BK4007":"制药","TSLA":"特斯拉","COMP":"Compass, Inc.",".DJI":"道琼斯","PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193113147","content_text":"* Consumer confidence index increases in December\n* U.S. Q3 economic growth revised slightly higher\n* Tesla jumps as CEO Musk says he has sold 'enough' stock\n* Pfizer rises as oral COVID-19 pill wins approval\n* Indexes up: Dow 0.74%, S&P 1.02%, Nasdaq 1.18% \nDec 22 (Reuters) - Wall Street's main indexes powered higher on Wednesday in a broad rally after upbeat economic data and hopeful developments about the severity of the Omicron coronavirus variant that is sweeping the world.\nThe S&P 500 gained at least 1% for a second straight session, putting it near record levels, as volatility has ratcheted up in the last month of 2021 following the arrival of Omicron and an otherwise strong year for equities.\nA South African study suggested reduced risks of hospitalization and severe disease in people infected with the Omicron variant versus the Delta one, but World Health Organization officials cautioned that it was too soon to draw firm conclusions.\n“We are still struggling for direction in the face of the Omicron outbreak, but in the past few days ... more and more evidence is building that the strain is potentially less severe than prior strains, specifically Delta, which bodes well for economic momentum in 2022,” said Mike Stritch, chief investment officer at BMO Wealth Management.\nThe Dow Jones Industrial Average rose 261.19 points, or 0.74%, to 35,753.89, the S&P 500 gained 47.33 points, or 1.02%, to 4,696.56 and the Nasdaq Composite added 180.81 points, or 1.18%, to 15,521.89.\nAll major S&P 500 sectors gained, with the consumer discretionary group up 1.7% and technology up 1.3%.\nTesla Inc shares rose 7.5%, boosting the S&P 500 and Nasdaq. Tesla Chief Executive Elon Musk said in an interview he has sold \"enough stock\" following several weeks of share sales by the billionaire.\nU.S. consumer confidence improved further in December, suggesting the economy would continue to expand in 2022. The survey from the Conference Board showed more consumers planned to buy a house and big-ticket items such as motor vehicles and major household appliances as well as go on vacation over the next six months.\nOther reports showed U.S. home sales increased for a third straight month in November, and that gross domestic product increased at a 2.3% annualized rate in the July-September quarter, revised up from the 2.1% rate estimated last month.\nIn another encouraging development against the pandemic, the United States authorized Pfizer Inc's oral antiviral COVID-19 pill for at-risk people aged 12 and above, making it the first at-home treatment for the coronavirus. Pfizer shares rose 1%.\nThe benchmark S&P 500 is now up 25% so far in 2021. Still, the environment for equities could be changing heading into next year as the Federal Reserve is expected to begin raising interest rates in 2022 to rein in inflation.\nThe market is \"certainly at an extended level of valuation,\" said Rick Meckler, partner at Cherry Lane Investments in New Vernon, New Jersey. “Next year is a more difficult picture, but if inflation is going to be part of the problem, I think investors will certainly choose stocks over bonds.”\nAdvancing issues outnumbered declining ones on the NYSE by a 3.17-to-1 ratio; on Nasdaq, a 1.65-to-1 ratio favored advancers.\nThe S&P 500 posted 15 new 52-week highs and no new lows; the Nasdaq Composite recorded 35 new highs and 99 new lows.\nAbout 8.6 billion shares changed hands in U.S. exchanges, below the 11.8 billion daily average over the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":651,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":381619781,"gmtCreate":1612961321443,"gmtModify":1703767502086,"author":{"id":"3573977348324837","authorId":"3573977348324837","name":"CrimsonHeart","avatar":"https://static.tigerbbs.com/c790b0ebdf77e67f8dccdd2fe317727f","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573977348324837","authorIdStr":"3573977348324837"},"themes":[],"htmlText":"O.o...","listText":"O.o...","text":"O.o...","images":[{"img":"https://static.tigerbbs.com/3d7d07f69197d44f5412e73e1f2f3275","width":"1080","height":"2538"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/381619781","isVote":1,"tweetType":1,"viewCount":78,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":312392941,"gmtCreate":1612013411683,"gmtModify":1703757437324,"author":{"id":"3573977348324837","authorId":"3573977348324837","name":"CrimsonHeart","avatar":"https://static.tigerbbs.com/c790b0ebdf77e67f8dccdd2fe317727f","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573977348324837","authorIdStr":"3573977348324837"},"themes":[],"htmlText":"......","listText":"......","text":"......","images":[{"img":"https://static.tigerbbs.com/88c2b4c00345ce1b0571b7bc60763bff","width":"1080","height":"2009"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":7,"repostSize":0,"link":"https://laohu8.com/post/312392941","isVote":1,"tweetType":1,"viewCount":119,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3527667803686145","authorId":"3527667803686145","name":"社区成长助手","avatar":"https://static.tigerbbs.com/2b7c7106b5c0c8b0037faa67439d898f","crmLevel":1,"crmLevelSwitch":0,"idStr":"3527667803686145","authorIdStr":"3527667803686145"},"content":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看老虎社区创作指引","text":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看老虎社区创作指引","html":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看老虎社区创作指引"}],"imageCount":1,"langContent":"EN","totalScore":0}],"hots":[{"id":312392941,"gmtCreate":1612013411683,"gmtModify":1703757437324,"author":{"id":"3573977348324837","authorId":"3573977348324837","name":"CrimsonHeart","avatar":"https://static.tigerbbs.com/c790b0ebdf77e67f8dccdd2fe317727f","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573977348324837","idStr":"3573977348324837"},"themes":[],"htmlText":"......","listText":"......","text":"......","images":[{"img":"https://static.tigerbbs.com/88c2b4c00345ce1b0571b7bc60763bff","width":"1080","height":"2009"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":7,"repostSize":0,"link":"https://laohu8.com/post/312392941","isVote":1,"tweetType":1,"viewCount":119,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3527667803686145","authorId":"3527667803686145","name":"社区成长助手","avatar":"https://static.tigerbbs.com/2b7c7106b5c0c8b0037faa67439d898f","crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3527667803686145","idStr":"3527667803686145"},"content":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看老虎社区创作指引","text":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看老虎社区创作指引","html":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看老虎社区创作指引"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":691421468,"gmtCreate":1640230064615,"gmtModify":1640230064671,"author":{"id":"3573977348324837","authorId":"3573977348324837","name":"CrimsonHeart","avatar":"https://static.tigerbbs.com/c790b0ebdf77e67f8dccdd2fe317727f","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573977348324837","idStr":"3573977348324837"},"themes":[],"htmlText":":D","listText":":D","text":":D","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691421468","repostId":"2193113147","repostType":4,"repost":{"id":"2193113147","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640213688,"share":"https://www.laohu8.com/m/news/2193113147?lang=&edition=full","pubTime":"2021-12-23 06:54","market":"us","language":"en","title":"Wall St mints strong gains on rosy economic data, encouraging Omicron update","url":"https://stock-news.laohu8.com/highlight/detail?id=2193113147","media":"Reuters","summary":"* Tesla jumps as CEO Musk says he has sold 'enough' stock. * Pfizer rises as oral COVID-19 pill wins approval. Dec 22  - Wall Street's main indexes powered higher on Wednesday in a broad rally after upbeat economic data and hopeful developments about the severity of the Omicron coronavirus variant that is sweeping the world.The S&P 500 gained at least 1% for a second straight session, putting it near record levels, as volatility has ratcheted up in the last month of 2021 following the arrival of","content":"<p>* Consumer confidence index increases in December</p>\n<p>* U.S. Q3 economic growth revised slightly higher</p>\n<p>* Tesla jumps as CEO Musk says he has sold 'enough' stock</p>\n<p>* Pfizer rises as oral COVID-19 pill wins approval</p>\n<p>* Indexes up: Dow 0.74%, S&amp;P 1.02%, Nasdaq 1.18% </p>\n<p>Dec 22 (Reuters) - Wall Street's main indexes powered higher on Wednesday in a broad rally after upbeat economic data and hopeful developments about the severity of the Omicron coronavirus variant that is sweeping the world.</p>\n<p>The S&amp;P 500 gained at least 1% for a second straight session, putting it near record levels, as volatility has ratcheted up in the last month of 2021 following the arrival of Omicron and an otherwise strong year for equities.</p>\n<p>A South African study suggested reduced risks of hospitalization and severe disease in people infected with the Omicron variant versus the Delta one, but World Health Organization officials cautioned that it was too soon to draw firm conclusions.</p>\n<p>“We are still struggling for direction in the face of the Omicron outbreak, but in the past few days ... more and more evidence is building that the strain is potentially less severe than prior strains, specifically Delta, which bodes well for economic momentum in 2022,” said Mike Stritch, chief investment officer at BMO Wealth Management.</p>\n<p>The Dow Jones Industrial Average rose 261.19 points, or 0.74%, to 35,753.89, the S&amp;P 500 gained 47.33 points, or 1.02%, to 4,696.56 and the Nasdaq Composite added 180.81 points, or 1.18%, to 15,521.89.</p>\n<p>All major S&amp;P 500 sectors gained, with the consumer discretionary group up 1.7% and technology up 1.3%.</p>\n<p>Tesla Inc shares rose 7.5%, boosting the S&amp;P 500 and Nasdaq. Tesla Chief Executive Elon Musk said in an interview he has sold \"enough stock\" following several weeks of share sales by the billionaire.</p>\n<p>U.S. consumer confidence improved further in December, suggesting the economy would continue to expand in 2022. The survey from the Conference Board showed more consumers planned to buy a house and big-ticket items such as motor vehicles and major household appliances as well as go on vacation over the next six months.</p>\n<p>Other reports showed U.S. home sales increased for a third straight month in November, and that gross domestic product increased at a 2.3% annualized rate in the July-September quarter, revised up from the 2.1% rate estimated last month.</p>\n<p>In another encouraging development against the pandemic, the United States authorized Pfizer Inc's oral antiviral COVID-19 pill for at-risk people aged 12 and above, making it the first at-home treatment for the coronavirus. Pfizer shares rose 1%.</p>\n<p>The benchmark S&amp;P 500 is now up 25% so far in 2021. Still, the environment for equities could be changing heading into next year as the Federal Reserve is expected to begin raising interest rates in 2022 to rein in inflation.</p>\n<p>The market is \"certainly at an extended level of valuation,\" said Rick Meckler, partner at Cherry Lane Investments in New Vernon, New Jersey. “Next year is a more difficult picture, but if inflation is going to be part of the problem, I think investors will certainly choose stocks over bonds.”</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 3.17-to-1 ratio; on Nasdaq, a 1.65-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 15 new 52-week highs and no new lows; the Nasdaq Composite recorded 35 new highs and 99 new lows.</p>\n<p>About 8.6 billion shares changed hands in U.S. exchanges, below the 11.8 billion daily average over the last 20 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St mints strong gains on rosy economic data, encouraging Omicron update</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St mints strong gains on rosy economic data, encouraging Omicron update\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-23 06:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* Consumer confidence index increases in December</p>\n<p>* U.S. Q3 economic growth revised slightly higher</p>\n<p>* Tesla jumps as CEO Musk says he has sold 'enough' stock</p>\n<p>* Pfizer rises as oral COVID-19 pill wins approval</p>\n<p>* Indexes up: Dow 0.74%, S&amp;P 1.02%, Nasdaq 1.18% </p>\n<p>Dec 22 (Reuters) - Wall Street's main indexes powered higher on Wednesday in a broad rally after upbeat economic data and hopeful developments about the severity of the Omicron coronavirus variant that is sweeping the world.</p>\n<p>The S&amp;P 500 gained at least 1% for a second straight session, putting it near record levels, as volatility has ratcheted up in the last month of 2021 following the arrival of Omicron and an otherwise strong year for equities.</p>\n<p>A South African study suggested reduced risks of hospitalization and severe disease in people infected with the Omicron variant versus the Delta one, but World Health Organization officials cautioned that it was too soon to draw firm conclusions.</p>\n<p>“We are still struggling for direction in the face of the Omicron outbreak, but in the past few days ... more and more evidence is building that the strain is potentially less severe than prior strains, specifically Delta, which bodes well for economic momentum in 2022,” said Mike Stritch, chief investment officer at BMO Wealth Management.</p>\n<p>The Dow Jones Industrial Average rose 261.19 points, or 0.74%, to 35,753.89, the S&amp;P 500 gained 47.33 points, or 1.02%, to 4,696.56 and the Nasdaq Composite added 180.81 points, or 1.18%, to 15,521.89.</p>\n<p>All major S&amp;P 500 sectors gained, with the consumer discretionary group up 1.7% and technology up 1.3%.</p>\n<p>Tesla Inc shares rose 7.5%, boosting the S&amp;P 500 and Nasdaq. Tesla Chief Executive Elon Musk said in an interview he has sold \"enough stock\" following several weeks of share sales by the billionaire.</p>\n<p>U.S. consumer confidence improved further in December, suggesting the economy would continue to expand in 2022. The survey from the Conference Board showed more consumers planned to buy a house and big-ticket items such as motor vehicles and major household appliances as well as go on vacation over the next six months.</p>\n<p>Other reports showed U.S. home sales increased for a third straight month in November, and that gross domestic product increased at a 2.3% annualized rate in the July-September quarter, revised up from the 2.1% rate estimated last month.</p>\n<p>In another encouraging development against the pandemic, the United States authorized Pfizer Inc's oral antiviral COVID-19 pill for at-risk people aged 12 and above, making it the first at-home treatment for the coronavirus. Pfizer shares rose 1%.</p>\n<p>The benchmark S&amp;P 500 is now up 25% so far in 2021. Still, the environment for equities could be changing heading into next year as the Federal Reserve is expected to begin raising interest rates in 2022 to rein in inflation.</p>\n<p>The market is \"certainly at an extended level of valuation,\" said Rick Meckler, partner at Cherry Lane Investments in New Vernon, New Jersey. “Next year is a more difficult picture, but if inflation is going to be part of the problem, I think investors will certainly choose stocks over bonds.”</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 3.17-to-1 ratio; on Nasdaq, a 1.65-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 15 new 52-week highs and no new lows; the Nasdaq Composite recorded 35 new highs and 99 new lows.</p>\n<p>About 8.6 billion shares changed hands in U.S. exchanges, below the 11.8 billion daily average over the last 20 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)",".IXIC":"NASDAQ Composite","BK4568":"美国抗疫概念","BK4007":"制药","TSLA":"特斯拉","COMP":"Compass, Inc.",".DJI":"道琼斯","PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193113147","content_text":"* Consumer confidence index increases in December\n* U.S. Q3 economic growth revised slightly higher\n* Tesla jumps as CEO Musk says he has sold 'enough' stock\n* Pfizer rises as oral COVID-19 pill wins approval\n* Indexes up: Dow 0.74%, S&P 1.02%, Nasdaq 1.18% \nDec 22 (Reuters) - Wall Street's main indexes powered higher on Wednesday in a broad rally after upbeat economic data and hopeful developments about the severity of the Omicron coronavirus variant that is sweeping the world.\nThe S&P 500 gained at least 1% for a second straight session, putting it near record levels, as volatility has ratcheted up in the last month of 2021 following the arrival of Omicron and an otherwise strong year for equities.\nA South African study suggested reduced risks of hospitalization and severe disease in people infected with the Omicron variant versus the Delta one, but World Health Organization officials cautioned that it was too soon to draw firm conclusions.\n“We are still struggling for direction in the face of the Omicron outbreak, but in the past few days ... more and more evidence is building that the strain is potentially less severe than prior strains, specifically Delta, which bodes well for economic momentum in 2022,” said Mike Stritch, chief investment officer at BMO Wealth Management.\nThe Dow Jones Industrial Average rose 261.19 points, or 0.74%, to 35,753.89, the S&P 500 gained 47.33 points, or 1.02%, to 4,696.56 and the Nasdaq Composite added 180.81 points, or 1.18%, to 15,521.89.\nAll major S&P 500 sectors gained, with the consumer discretionary group up 1.7% and technology up 1.3%.\nTesla Inc shares rose 7.5%, boosting the S&P 500 and Nasdaq. Tesla Chief Executive Elon Musk said in an interview he has sold \"enough stock\" following several weeks of share sales by the billionaire.\nU.S. consumer confidence improved further in December, suggesting the economy would continue to expand in 2022. The survey from the Conference Board showed more consumers planned to buy a house and big-ticket items such as motor vehicles and major household appliances as well as go on vacation over the next six months.\nOther reports showed U.S. home sales increased for a third straight month in November, and that gross domestic product increased at a 2.3% annualized rate in the July-September quarter, revised up from the 2.1% rate estimated last month.\nIn another encouraging development against the pandemic, the United States authorized Pfizer Inc's oral antiviral COVID-19 pill for at-risk people aged 12 and above, making it the first at-home treatment for the coronavirus. Pfizer shares rose 1%.\nThe benchmark S&P 500 is now up 25% so far in 2021. Still, the environment for equities could be changing heading into next year as the Federal Reserve is expected to begin raising interest rates in 2022 to rein in inflation.\nThe market is \"certainly at an extended level of valuation,\" said Rick Meckler, partner at Cherry Lane Investments in New Vernon, New Jersey. “Next year is a more difficult picture, but if inflation is going to be part of the problem, I think investors will certainly choose stocks over bonds.”\nAdvancing issues outnumbered declining ones on the NYSE by a 3.17-to-1 ratio; on Nasdaq, a 1.65-to-1 ratio favored advancers.\nThe S&P 500 posted 15 new 52-week highs and no new lows; the Nasdaq Composite recorded 35 new highs and 99 new lows.\nAbout 8.6 billion shares changed hands in U.S. exchanges, below the 11.8 billion daily average over the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":651,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691428502,"gmtCreate":1640230158215,"gmtModify":1640230158310,"author":{"id":"3573977348324837","authorId":"3573977348324837","name":"CrimsonHeart","avatar":"https://static.tigerbbs.com/c790b0ebdf77e67f8dccdd2fe317727f","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573977348324837","idStr":"3573977348324837"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691428502","repostId":"1137875320","repostType":4,"repost":{"id":"1137875320","kind":"news","pubTimestamp":1640228882,"share":"https://www.laohu8.com/m/news/1137875320?lang=&edition=full","pubTime":"2021-12-23 11:08","market":"us","language":"en","title":"HUBS Stock Alert: 8 Things to Know About the New HubSpot Short Report","url":"https://stock-news.laohu8.com/highlight/detail?id=1137875320","media":"InvestorPlace","summary":"Shares of HubSpot(NYSE:HUBS) have been on an absolute tear since the March 2020 pandemic lows. The m","content":"<p>Shares of&nbsp;<b>HubSpot</b>(NYSE:<b><u>HUBS</u></b>) have been on an absolute tear since the March 2020 pandemic lows. The marketing software solutions company has appreciated more than 450% since then. This return certainly beat the&nbsp;<b>S&amp;P 500’s</b>&nbsp;return of 103% during the same time period. However, a new short report released today by an influential hedge fund has investors of HUBS stock concerned.</p>\n<p><b>Kerrisdale Capital</b>, a New York based hedge fund, issued a scathing&nbsp;short report&nbsp;on HUBS stock. The fund believes that HubSpot is a massively overvalued coronavirus beneficiary that lacks a real moat. A moat is a competitive advantage that a company has that gives it a unique edge over competitors. Additionally, a moat gives a company power to control market share and sales. Kerrisdale adds that HubSpot is unprofitable, yet still trades at 20x forward revenue.</p>\n<p>Shares of HUBS stock have remained relatively resilient in the wake of Kerrisdale’s short report, down less than 2%. However, when Kerrisdale talks, people listen. Let’s dive into the details on the HubSpot short report.</p>\n<p>What to Know About the Kerrisdale Short Report Rocking HUBS Stock</p>\n<ol>\n <li>Kerrisdale highlights that HubSpot has a recent history of major executives leaving. In the past few years, the company has lost its CEO, chief operating officer, chief sales officer and chief strategy officer.</li>\n <li>Prior to the 2020 pandemic, HubSpot’s revenue growth was in decline for several years. Kerrisdale gives credit to HubSpot for growing revenues after the pandemic due to mid-sized businesses rushing to go digital. However, the hedge fund argues that the price of HubSpot is now trading at a premium relative to industry peers for no solid reason.</li>\n <li>Indeed, industry peers&nbsp;<b>SquareSpace</b>(NYSE:<b><u>SQSP</u></b>)&nbsp;and&nbsp;<b>Wix</b>(NASDAQ:<b><u>WIX</u></b>) trade at an enterprise value to next 12 months revenue (EV/NTM revenue) multiple of 5.1x and 5.7x, respectively. Meanwhile, HubSpot trades at a 20x EV/NTM sales multiple.</li>\n <li>Kerrisdale believes this multiple will be unsustainable for HubSpot as pandemic beneficiary companies start to return to normal and investors begin questioning unprofitable companies.</li>\n <li>According to Kerrisdale’s research and interviews with online marketing professionals, HubSpot’s products are “‘good enough’ for many purposes but don’t possess any sort of commanding lead in capabilities or ease of use.” The hedge fund cites several online reviews that mention that the company’s variety of products doesn’t offer any real utility. Furthermore, several online reviews detail the difficulty of HubSpot’s learning curve and expensive prices.</li>\n <li>Moreover, HubSpot has raised capital in the past few years “with no obvious use for it.” The company conducted a $343 million secondary equity offering in 2019 and issued convertible bonds worth $460 million in 2020. Kerrisdale explains that all of the cash raised from these two transactions is still sitting on the balance sheet. The hedge fund believes that the cash was simply raised to extend HubSpot’s financial runway. Moreover, the capital raise took advantage of “share prices that seemed high at the time (yet now imply dramatic downside for the stock).”</li>\n <li>As the digital transformation moves on, competitors to HubSpot are receiving capital easily. Kerrisdale highlights<b>Klaviyo</b>,<b>Mailchimp</b>&nbsp;and&nbsp;<b>SharpSpring</b>&nbsp;as three major competitors. Kerrisdale mentions that: “With its startup days now long behind it, HubSpot isn’t the disruptor; it’s the disruptee.”</li>\n <li>Finally, Kerrisdale Capital disclosed that it is short shares of HUBS stock.</li>\n</ol>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HUBS Stock Alert: 8 Things to Know About the New HubSpot Short Report</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHUBS Stock Alert: 8 Things to Know About the New HubSpot Short Report\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-23 11:08 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/12/hubs-stock-alert-8-things-to-know-about-the-new-hubspot-short-report/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of HubSpot(NYSE:HUBS) have been on an absolute tear since the March 2020 pandemic lows. The marketing software solutions company has appreciated more than 450% since then. This return certainly...</p>\n\n<a href=\"https://investorplace.com/2021/12/hubs-stock-alert-8-things-to-know-about-the-new-hubspot-short-report/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HUBS":"HubSpot"},"source_url":"https://investorplace.com/2021/12/hubs-stock-alert-8-things-to-know-about-the-new-hubspot-short-report/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1137875320","content_text":"Shares of HubSpot(NYSE:HUBS) have been on an absolute tear since the March 2020 pandemic lows. The marketing software solutions company has appreciated more than 450% since then. This return certainly beat the S&P 500’s return of 103% during the same time period. However, a new short report released today by an influential hedge fund has investors of HUBS stock concerned.\nKerrisdale Capital, a New York based hedge fund, issued a scathing short report on HUBS stock. The fund believes that HubSpot is a massively overvalued coronavirus beneficiary that lacks a real moat. A moat is a competitive advantage that a company has that gives it a unique edge over competitors. Additionally, a moat gives a company power to control market share and sales. Kerrisdale adds that HubSpot is unprofitable, yet still trades at 20x forward revenue.\nShares of HUBS stock have remained relatively resilient in the wake of Kerrisdale’s short report, down less than 2%. However, when Kerrisdale talks, people listen. Let’s dive into the details on the HubSpot short report.\nWhat to Know About the Kerrisdale Short Report Rocking HUBS Stock\n\nKerrisdale highlights that HubSpot has a recent history of major executives leaving. In the past few years, the company has lost its CEO, chief operating officer, chief sales officer and chief strategy officer.\nPrior to the 2020 pandemic, HubSpot’s revenue growth was in decline for several years. Kerrisdale gives credit to HubSpot for growing revenues after the pandemic due to mid-sized businesses rushing to go digital. However, the hedge fund argues that the price of HubSpot is now trading at a premium relative to industry peers for no solid reason.\nIndeed, industry peers SquareSpace(NYSE:SQSP) and Wix(NASDAQ:WIX) trade at an enterprise value to next 12 months revenue (EV/NTM revenue) multiple of 5.1x and 5.7x, respectively. Meanwhile, HubSpot trades at a 20x EV/NTM sales multiple.\nKerrisdale believes this multiple will be unsustainable for HubSpot as pandemic beneficiary companies start to return to normal and investors begin questioning unprofitable companies.\nAccording to Kerrisdale’s research and interviews with online marketing professionals, HubSpot’s products are “‘good enough’ for many purposes but don’t possess any sort of commanding lead in capabilities or ease of use.” The hedge fund cites several online reviews that mention that the company’s variety of products doesn’t offer any real utility. Furthermore, several online reviews detail the difficulty of HubSpot’s learning curve and expensive prices.\nMoreover, HubSpot has raised capital in the past few years “with no obvious use for it.” The company conducted a $343 million secondary equity offering in 2019 and issued convertible bonds worth $460 million in 2020. Kerrisdale explains that all of the cash raised from these two transactions is still sitting on the balance sheet. The hedge fund believes that the cash was simply raised to extend HubSpot’s financial runway. Moreover, the capital raise took advantage of “share prices that seemed high at the time (yet now imply dramatic downside for the stock).”\nAs the digital transformation moves on, competitors to HubSpot are receiving capital easily. Kerrisdale highlightsKlaviyo,Mailchimp and SharpSpring as three major competitors. Kerrisdale mentions that: “With its startup days now long behind it, HubSpot isn’t the disruptor; it’s the disruptee.”\nFinally, Kerrisdale Capital disclosed that it is short shares of HUBS stock.","news_type":1},"isVote":1,"tweetType":1,"viewCount":540,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691422974,"gmtCreate":1640230337572,"gmtModify":1640230406468,"author":{"id":"3573977348324837","authorId":"3573977348324837","name":"CrimsonHeart","avatar":"https://static.tigerbbs.com/c790b0ebdf77e67f8dccdd2fe317727f","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573977348324837","idStr":"3573977348324837"},"themes":[],"htmlText":"Weeeeee","listText":"Weeeeee","text":"Weeeeee","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691422974","isVote":1,"tweetType":1,"viewCount":501,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":381619781,"gmtCreate":1612961321443,"gmtModify":1703767502086,"author":{"id":"3573977348324837","authorId":"3573977348324837","name":"CrimsonHeart","avatar":"https://static.tigerbbs.com/c790b0ebdf77e67f8dccdd2fe317727f","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573977348324837","idStr":"3573977348324837"},"themes":[],"htmlText":"O.o...","listText":"O.o...","text":"O.o...","images":[{"img":"https://static.tigerbbs.com/3d7d07f69197d44f5412e73e1f2f3275","width":"1080","height":"2538"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/381619781","isVote":1,"tweetType":1,"viewCount":78,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"lives":[]}